Trials / Terminated
TerminatedNCT02419703
The STAR™ Tumor Ablation Registry
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (actual)
- Sponsor
- Merit Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
Registry collecting data on use of The STAR™ Tumor Ablation System.
Detailed description
The STAR Prospective Registry is an observational registry to gather clinical safety and outcome data in patients with painful spinal metastases in the thoracolumbar spine (T1-L5) following targeted radiofrequency ablation (t-RFA) treatment with the STAR™ Tumor Ablation System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | STAR™ Tumor Ablation System | Targeted Radiofrequency ablation of painful metastatic tumor in the vertebral body. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-03-20
- Completion
- 2017-03-20
- First posted
- 2015-04-17
- Last updated
- 2017-04-12
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02419703. Inclusion in this directory is not an endorsement.